Type 2 diabetes is a prevalent disease that increases the risk for vascular, renal, and neurologic complications. Prevention and treatment of type 2 diabetes and its complications are of paramount importance. Many advancements in type 2 diabetes care have emerged over the past 5 years, including increased understanding of the importance of early intensive glycemic control, mental health, social determinants of health, healthy eating patterns, continuous glucose monitoring, and the benefits of some drugs for preventing cardiorenal disease. This review summarizes the evidence supporting type 2 diabetes prevention and treatment, focusing on aspects that are commonly in the purview of primary care physicians.
Use this to:
- Review the risk factors for type 2 diabetes.
- Study the recommendations for treatment of type 2 diabetes.
- Review the for use of newer pharmacologic treatments for type 2 diabetes.
- Ask a pharmacist to discuss SGLT-2 inhibitors or glucagon-like peptide-1 agonists, how to choose which drug to prescribe, and how to counsel patients before initiation.
In the Clinic is a feature of Annals of Internal Medicine which includes practical reviews about the management of common clinical conditions.
Back to the August 2024 issue of ACP IMpact